Abstract
Several patterns of maladaptive behaviors share their clinical features with those of substance use disorders such as tolerance, withdrawal, repeated unsuccessful attempts to cut back or quit, and interference in major areas of life function, thus gaining the name of “behavioral addictions”. Several studies showed that behavioral addictions and substance addictions share a similar pattern of brain activation during symptom provocation tasks, suggesting a common neurobiological substrate. However, despite the growing knowledge on the neurobiological underpinnings of behavioral addictions, treatment of these conditions is still controversial. Research Domain Criteria project would help in identifying circuitry involved in complex behavioral syndromes such as addiction either to substances or not-substances. The purpose of this review is to summarize current knowledge of the different pharmacological approaches to behavioral addictions. In particular, we will focus on the pharmacological treatment of pathological gambling, internet addiction and hypersexual disorder.
Keywords: Addictions, hypersexual disorder, maladaptive behaviors, pathological gambling.
Current Psychopharmacology
Title:Pharmacological Treatments for Behavioral Addictions: From Behavioral Dimensions to the Research Domain Criteria Based Target
Volume: 2 Issue: 3
Author(s): Stefano Pallanti, Giacomo Grassi, Tommaso Tofani and Silvia Spitoni
Affiliation:
Keywords: Addictions, hypersexual disorder, maladaptive behaviors, pathological gambling.
Abstract: Several patterns of maladaptive behaviors share their clinical features with those of substance use disorders such as tolerance, withdrawal, repeated unsuccessful attempts to cut back or quit, and interference in major areas of life function, thus gaining the name of “behavioral addictions”. Several studies showed that behavioral addictions and substance addictions share a similar pattern of brain activation during symptom provocation tasks, suggesting a common neurobiological substrate. However, despite the growing knowledge on the neurobiological underpinnings of behavioral addictions, treatment of these conditions is still controversial. Research Domain Criteria project would help in identifying circuitry involved in complex behavioral syndromes such as addiction either to substances or not-substances. The purpose of this review is to summarize current knowledge of the different pharmacological approaches to behavioral addictions. In particular, we will focus on the pharmacological treatment of pathological gambling, internet addiction and hypersexual disorder.
Export Options
About this article
Cite this article as:
Pallanti Stefano, Grassi Giacomo, Tofani Tommaso and Spitoni Silvia, Pharmacological Treatments for Behavioral Addictions: From Behavioral Dimensions to the Research Domain Criteria Based Target, Current Psychopharmacology 2013; 2(3) . https://dx.doi.org/10.2174/22115560113029990002
DOI https://dx.doi.org/10.2174/22115560113029990002 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
TRH/TRH-R1 Receptor Signaling in the Brain Medulla as a Pathway of Vagally Mediated Gut Responses During the Cephalic Phase
Current Pharmaceutical Design The Role of Viruses in Neurodegenerative and Neurobehavioral Diseases
CNS & Neurological Disorders - Drug Targets Cellular and Biochemical Actions of Melatonin which Protect Against Free Radicals: Role in Neurodegenerative Disorders
Current Neuropharmacology Activity-dependent Synaptic Plasticity and Metaplasticity in Spinal Motor Networks
Current Pharmaceutical Design Prevalence of Comorbid Anxiety Disorders in Schizophrenia Spectrum Disorders: A Literature Review
Current Psychiatry Reviews Synthetic and Medicinal Prospective of Structurally Modified Curcumins
Current Topics in Medicinal Chemistry Experimental Treatment Options in Absence Epilepsy
Current Pharmaceutical Design Cardiovascular Effects of Methotrexate in Rheumatoid Arthritis Revisited
Current Medicinal Chemistry Pharmacological Prolyl Hydroxylase Domain Inhibition as a Therapeutic Target for Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Cellular Mechanisms Underlying the Interaction between Cannabinoid and Opioid System
Current Drug Targets Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy
Current Neuropharmacology Molecular Chaperones as Rational Drug Targets for Parkinsons Disease Therapeutics
CNS & Neurological Disorders - Drug Targets Heteromerization of G Protein-Coupled Receptors: Relevance to Neurological Disorders and Neurotherapeutics
CNS & Neurological Disorders - Drug Targets Postoperative Delirium
Current Drug Targets Depression and Vascular Disease: Conceptual Issues, Relationships and Clinical Implications
Vascular Disease Prevention (Discontinued) Possible Involvement of Muscarinic Receptors in Psychiatric Disorders: A Focus on Schizophrenia and Mood Disorders
Current Molecular Medicine Nitric Oxide in the Dorsal Medulla Modulates Excitatory Somatosympathetic Reflexes
Current Cardiology Reviews Sigma Receptors and Cocaine Abuse
Current Topics in Medicinal Chemistry Seeing Genes at Work in the Living Brain with Non-Invasive Molecular Imaging
Current Gene Therapy Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers
Current Medicinal Chemistry